☰

Eugene J. Wyatt, Ph.D. - Publications

Affiliations: 
2012 Integrated Graduate Program in the Life Sciences Northwestern University, Evanston, IL 
Area:
Cell Biology
Tree Info Similar researchers PubMed Report error

11 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Marcheva B, Perelis M, Weidemann BJ, Taguchi A, Lin H, Omura C, Kobayashi Y, Newman MV, Wyatt EJ, McNally EM, Fox JEM, Hong H, Shankar A, Wheeler EC, Ramsey KM, et al. A role for alternative splicing in circadian control of exocytosis and glucose homeostasis. Genes & Development. PMID 32616519 DOI: 10.1101/Gad.338178.120  0.363
2019 Demonbreun AR, Wyatt EJ, Fallon KS, Oosterbaan CC, Page P, Hadhazy M, Quattrocelli M, Barefield DY, McNally EM. A gene-edited mouse model of Limb-Girdle muscular dystrophy 2C for testing exon skipping. Disease Models & Mechanisms. PMID 31582396 DOI: 10.1242/Dmm.040832  0.351
2019 Kim EY, Barefield DY, Vo AH, Gacita AM, Schuster EJ, Wyatt EJ, Davis JL, Dong B, Sun C, Page P, Dellefave-Castillo L, Demonbreun A, Zhang HF, McNally EM. Distinct pathological signatures in human cellular models of myotonic dystrophy subtypes. Jci Insight. PMID 30730308 DOI: 10.1172/Jci.Insight.122686  0.31
2018 Wyatt EJ, Demonbreun AR, Kim EY, Puckelwartz MJ, Vo AH, Dellefave-Castillo LM, Gao QQ, Vainzof M, Pavanello RCM, Zatz M, McNally EM. Efficient exon skipping of SGCG mutations mediated by phosphorodiamidate morpholino oligomers. Jci Insight. 3. PMID 29720576 DOI: 10.1172/Jci.Insight.99357  0.347
2017 McNally EM, Wyatt EJ. Mutation-Based Therapy for Duchenne Muscular Dystrophy: Antisense Treatment Arrives in the Clinic. Circulation. 136: 979-981. PMID 28893959 DOI: 10.1161/Circulationaha.117.028382  0.305
2016 Kim EY, Page P, Dellefave-Castillo LM, McNally EM, Wyatt EJ. Direct reprogramming of urine-derived cells with inducible MyoD for modeling human muscle disease. Skeletal Muscle. 6: 32. PMID 27651888 DOI: 10.1186/S13395-016-0103-9  0.301
2016 McNally EM, Wyatt EJ. Welcome to the splice age: antisense oligonucleotide-mediated exon skipping gains wider applicability. The Journal of Clinical Investigation. 126: 1236-8. PMID 26999602 DOI: 10.1172/Jci86799  0.347
2015 Gao QQ, Wyatt E, Goldstein JA, LoPresti P, Castillo LM, Gazda A, Petrossian N, Earley JU, Hadhazy M, Barefield DY, Demonbreun AR, Bönnemann C, Wolf M, McNally EM. Reengineering a transmembrane protein to treat muscular dystrophy using exon skipping. The Journal of Clinical Investigation. PMID 26457733 DOI: 10.1172/Jci82768  0.352
2012 Wu R, Wyatt E, Chawla K, Tran M, Ghanefar M, Laakso M, Epting CL, Ardehali H. Hexokinase II knockdown results in exaggerated cardiac hypertrophy via increased ROS production. Embo Molecular Medicine. 4: 633-46. PMID 22517678 DOI: 10.1002/Emmm.201200240  0.532
2011 Wu R, Smeele KM, Wyatt E, Ichikawa Y, Eerbeek O, Sun L, Chawla K, Hollmann MW, Nagpal V, Heikkinen S, Laakso M, Jujo K, Wasserstrom JA, Zuurbier CJ, Ardehali H. Reduction in hexokinase II levels results in decreased cardiac function and altered remodeling after ischemia/reperfusion injury. Circulation Research. 108: 60-9. PMID 21071708 DOI: 10.1161/Circresaha.110.223115  0.528
2010 Wyatt E, Wu R, Rabeh W, Park HW, Ghanefar M, Ardehali H. Regulation and cytoprotective role of hexokinase III. Plos One. 5: e13823. PMID 21072205 DOI: 10.1371/Journal.Pone.0013823  0.526
Show low-probability matches.